For example, PARP inhibitors, while effective at exploiting vulnerabilities in tumor cells, can also promote the accumulation of DNA breaks via PARP trapping, leading to increased cytosolic DNA and activation of innate immune sensors, including the cGAS‐STING pathway [123]. The gene discussed is PARP1; the disease is neoplasm.